AHA: FTC approach to reviewing hospital transactions seriously flawed

The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly credit the many pro-consumer benefits of hospital transactions, and ignores key realities of the marketplace,” according to an analysis submitted to the agency for a series of FTC hearings on Competition and Consumer Protection in the 21st Century. Performed for the AHA by Charles River Associates in conjunction with antitrust counsel at Wilson Sonsini Goodrich & Rosati, the analysis describes “serious flaws” in the supply and demand models that the FTC uses to evaluate the competitive effects of hospital transactions.

Related Resources

Letter/Comment
Member Non-Fed
Letter/Comment
Public
The American Hospital Association's comments on the Medicare Payment Advisory Commission’s (MedPAC) discussions on consolidation within the health care…
Letter/Comment
Public
AHA comments on the Centers for Medicare & Medicaid Services’ request for information on reducing administrative burden. As we have expressed to CMS,…
Letter/Comment
Public
AHA comments on the Centers for Medicare & Medicaid Services’ proposed guidance for hospital co-location with other hospitals or health care…
Letter/Comment
Public
AHA’s comments in response to the Federal Trade Commission's request for comments in connection with the Commission's Certificate of Public Advantage ("COPA")…
Testimony
Public
March 7 – AHA Statement Before the House Committee on the Judiciary’s Subcommittee on Antitrust, Commercial and Administrative Law Exploring the Effects of…